From the Journals

New frontier: Transgender men yield eggs, babies, even after testosterone


 

Puberty blocking and fertility

When asked whether a transgender man who had undergone puberty blocking before transitioning (i.e., someone who had not gone through natural puberty) would be able to follow a similar course to pregnancy as the study participants, Dr. Resetkova acknowledged that is a more challenging area.

“We have little data so it’s hard to be conclusive, but it’s unlikely these patients would have mature hormonal responses and the ovaries might be in a naive state,” she hypothesized. “I don’t know that they would retain so many options as someone who had gone through natural puberty.”

“However, there are research protocols in place at some academic institutions for transgender patients planning to undergo puberty blocking,” she observed.

Finally, referring to individuals who transition from male to female using estrogen therapy, Dr. Resetkova said that the quality of sperm production might be impaired with long-term estrogen exposure. She added that other centers are looking at this.

“As transgender individuals increasingly seek access to reproductive services, we seek to shed light on the optimal way to provide effective care to these patients,” Dr. Dr. Resetkova and colleagues conclude.

Dr. Resetkova has reported no relevant financial relationships.

This article first appeared on Medscape.com.

SOURCE: Resetkova N et al. Fertil Steril. 2019;112:858-65.

Pages

Recommended Reading

Twin births down among women 30 and older
MDedge Endocrinology
SSRIs may reduce fecundability, live birth rate in reproductive-age women
MDedge Endocrinology
Elagolix with add-back therapy appears efficacious despite uterine and fibroid factors
MDedge Endocrinology
New drug improves sex drive, at least on paper
MDedge Endocrinology
Lifestyle program improves chance of spontaneous conception for women with obesity
MDedge Endocrinology
Preconception marijuana use by male partner raises spontaneous abortion risk
MDedge Endocrinology
FDA advisory committee supports birth control patch approval
MDedge Endocrinology
Multidisciplinary care could address fertility preservation in transgender youth
MDedge Endocrinology
Women undergoing hysterectomy, myomectomy have similar short-term outcomes
MDedge Endocrinology
Elagolix is effective second-tier treatment for endometriosis-associated dysmenorrhea
MDedge Endocrinology